Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Swedish trial of shortened postoperative antibiotics for pediatric perforated appendicitis
2026-525977-38-00Phase 4Authorised
- Sponsor
- Region Västra Götaland
- Start
- Nov 2026
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metronidazole, piperacillin + tazobactam, amoxicillin + clavulanate, cefotaxime, ciprofloxacin and 1 more in appendicitis (2 arms), sponsored by Region Västra Götaland. Primary endpoint: Postoperative infectious complications within 30 days. Planned start Nov 2026; status: authorised.
02
Drugs
metronidazolepiperacillin + tazobactamamoxicillin + clavulanatecefotaximeciprofloxacin
03
Conditions
appendicitis
Beyond the preview
Go deeper on 2026-525977-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525977-38-00.